Bipartisan PRICED Act Introduced in Congress
Three members of Congress, a bipartisan trio that spans both the House and the Senate, have introduced the Price Relief,…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Annual Forum on Transparency and Aggregate Spend
The Tenth Annual Forum on Transparency and Aggregate Spend will be held August 15 – 17, 2016, at the Ritz-Carlton in…
Valeant Finally Able to Close One Troubled Door with Salix Settlement
Salix, a subsidiary of Valeant Pharmaceuticals International, Inc., recently settled claims involving Anti-Kickback and…
Independent Payment Advisory Board (IPAB) What is Happening Now
The Independent Payment Advisory Board (IPAB) is one of the "cost control mechanisms" that can be found within the…
AMA, AAFP and Medical Societies Support Senate Bill Promoting CME Exemption…
A long list of over one hundred specialty groups and state medical societies penned a joint letter to Senator John Barrasso…
CMS Receives Hundreds of Comments to include CME in MACRA
With the nearly 4,000 comments now in for the proposed MACRA rule, we are taking a look at what organizations had to say…
The Latest DOJ Setback – Jury Acquits Former Warner Chilcott Senior…
With the acquittal of Carl Reichel, the Government's track record on securing convictions against individuals continues to be…
EFPIA Transparency Begins
Europe has recently pulled the trigger on their version of our Sunshine Act. While it is true that, with the exception…
Industry Expresses Concerns About FDA DTC Study
AbbVie, Eli Lilly, and Merck are all raising questions about the Food and Drug Administration's (FDA) plan to…
Webinar on EFPIA Disclosure Tomorrow, June 12
On June 30, 2016, pharmaceutical companies across Europe started to disclose their financial interactions with health care…